Article Information
Published By
Online ISSN
History
- Received December 2, 2020
- Accepted April 30, 2021
- Published online June 17, 2021.
Article Versions
- You are currently viewing a previous version of this article (June 17, 2021 - 07:22).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Emily P. Brigham1,
- Julie A. Anderson2,
- Robert D. Brook3,
- Peter M. A. Calverley4,
- Bartolome R. Celli5,
- Nicholas J. Cowans6,
- Courtney Crim7,
- James E. Diserens6,
- Fernando J. Martinez8,
- Meredith C. McCormack1,
- David E. Newby9,
- Julie Yates7,
- Jorgen Vestbo10,
- Tianshi David Wu11 and
- Robert A. Wise1
- 1Division of Pulmonary and Critical Care Medicine, Johns Hopkins Medicine, Baltimore, Maryland, USA
- 2Research & Development, GlaxoSmithKline, Stockley Park, Middlesex, UK
- 3Division of Cardiovascular Diseases, Wayne State University, Detroit, MI
- 4Department of Medicine, University of Liverpool, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK
- 5Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
- 6Statistics & Programming, Veramed Ltd., Twickenham, UK
- 7Research & Development, GlaxoSmithKline, Research Triangle Park, North Carolina, USA
- 8Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, New York, USA
- 9Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
- 10Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK
- 11Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Texas, USA
- Corresponding author: Emily P. Brigham (ebrigham{at}jhmi.edu)
Funding
GlaxoSmithKline
clinicaltrials.gov ID NCT01313676